Logo image of ABVE

ABOVE FOOD INGREDIENTS INC (ABVE) Stock Fundamental Analysis

NASDAQ:ABVE - Nasdaq - CA00373V1004 - Common Stock - Currency: USD

0.555  0 (0%)

After market: 0.5401 -0.01 (-2.68%)

Fundamental Rating

0

Overall ABVE gets a fundamental rating of 0 out of 10. We evaluated ABVE against 91 industry peers in the Food Products industry. ABVE has a bad profitability rating. Also its financial health evaluation is rather negative. ABVE is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

ABVE had negative earnings in the past year.
In the past year ABVE has reported a negative cash flow from operations.
ABVE Yearly Net Income VS EBIT VS OCF VS FCFABVE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 0 -1M -2M -3M

1.2 Ratios

The Return On Assets of ABVE (-1.03%) is worse than 69.41% of its industry peers.
ABVE has a worse Return On Equity (-1.24%) than 65.88% of its industry peers.
Industry RankSector Rank
ROA -1.03%
ROE -1.24%
ROIC N/A
ROA(3y)-0.11%
ROA(5y)N/A
ROE(3y)-0.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ABVE Yearly ROA, ROE, ROICABVE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 2 -2 -4 -6 -8

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for ABVE so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ABVE Yearly Profit, Operating, Gross MarginsABVE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023

More info and screens

1

2. Health

2.1 Basic Checks

The number of shares outstanding for ABVE has been reduced compared to 1 year ago.
Compared to 1 year ago, ABVE has a worse debt to assets ratio.
ABVE Yearly Shares OutstandingABVE Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 5M 10M 15M 20M 25M
ABVE Yearly Total Debt VS Total AssetsABVE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 50M 100M 150M 200M

2.2 Solvency

ABVE has an Altman-Z score of 1.34. This is a bad value and indicates that ABVE is not financially healthy and even has some risk of bankruptcy.
ABVE's Altman-Z score of 1.34 is on the low side compared to the rest of the industry. ABVE is outperformed by 70.59% of its industry peers.
A Debt/Equity ratio of 0.05 indicates that ABVE is not too dependend on debt financing.
ABVE has a better Debt to Equity ratio (0.05) than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Altman-Z 1.34
ROIC/WACCN/A
WACCN/A
ABVE Yearly LT Debt VS Equity VS FCFABVE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 50M 100M 150M

2.3 Liquidity

ABVE has a Current Ratio of 0.04. This is a bad value and indicates that ABVE is not financially healthy enough and could expect problems in meeting its short term obligations.
The Current ratio of ABVE (0.04) is worse than 98.82% of its industry peers.
A Quick Ratio of 0.04 indicates that ABVE may have some problems paying its short term obligations.
ABVE's Quick ratio of 0.04 is on the low side compared to the rest of the industry. ABVE is outperformed by 98.82% of its industry peers.
Industry RankSector Rank
Current Ratio 0.04
Quick Ratio 0.04
ABVE Yearly Current Assets VS Current LiabilitesABVE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The Earnings Per Share has grown by an nice 15.89% over the past year.
EPS 1Y (TTM)15.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.63%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ABVE Yearly Revenue VS EstimatesABVE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023
ABVE Yearly EPS VS EstimatesABVE Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

ABVE reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ABVE Price Earnings VS Forward Price EarningsABVE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ABVE Per share dataABVE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 0.4 0.6

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

ABVE does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ABOVE FOOD INGREDIENTS INC

NASDAQ:ABVE (2/21/2025, 8:00:00 PM)

After market: 0.5401 -0.01 (-2.68%)

0.555

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)11-18 2024-11-18
Earnings (Next)N/A N/A
Inst Owners0.29%
Inst Owner Change18.3%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap15.82M
AnalystsN/A
Price TargetN/A
Short Float %0.83%
Short Ratio0.51
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 0.75
P/tB 0.75
EV/EBITDA N/A
EPS(TTM)-0.03
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.06
OCFYN/A
SpS0
BVpS0.74
TBVpS0.74
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.03%
ROE -1.24%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-0.11%
ROA(5y)N/A
ROE(3y)-0.22%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score1
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.05
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.04
Quick Ratio 0.04
Altman-Z 1.34
F-Score1
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.89%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%96.63%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%N/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-38.92%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-207.79%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-207.79%
OCF growth 3YN/A
OCF growth 5YN/A